QURE – uniqure n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
2/7
09:12 am
qure
Medium
CSL Behring's Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia B
2/6
12:35 am
qure
Low
uniQure (NASDAQ: QURE) was upgraded by analysts at StockNews.com to a "sell" rating.
2/3
07:05 am
qure
High
uniQure Announces Completion of Enrollment in the First Cohort and Favorable Recommendation from the Independent Data Monitoring Committee for its Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease
1/30
07:37 am
qure
Medium
uniQure Announces Favorable Recommendation from Independent Data Monitoring Committee for its Phase I/II EPISOD1 Clinical Trial of AMT-162 for the Treatment of SOD1-ALS
1/27
08:02 am
qure
Low
uniQure (NASDAQ: QURE) had its price target raised by analysts at HC Wainwright from $25.00 to $70.00. They now have a "buy" rating on the stock.
11/5/2024
07:05 am
qure
11.2%
BEAT
8/1/2024
07:05 am
qure
-4.7%
BEAT
1/21
12:46 pm
Reiterates
Outperform
Outperform
Royal Bank of Canada
Low
2.7%
1/21
12:46 pm
Reiterates
Outperform
Outperform
Royal Bank of Canada
Low
2.7%
1/21
12:22 pm
Reiterates
Outperform
Outperform
RBC Capital
Low
2.7%
1/21
12:22 pm
Reiterates
Outperform
Outperform
RBC Capital
Low
2.7%
12/19
09:00 am
Maintains
Neutral
Neutral
Mizuho
Low
-2.6%
2/14
02:34 pm
qure
Low
Form SCHEDULE 13G/A uniQure N.V. Filed by: Vestal Point Capital, LP
1/8
04:25 pm
qure
High
Form 8-K uniQure N.V. For: Jan 07
1/8
04:22 pm
qure
High
Form 424B5 uniQure N.V.
1/7
05:25 pm
qure
Medium
Form 424B5 uniQure N.V.
1/7
04:44 pm
qure
Medium
Form S-3ASR uniQure N.V.
Show more
Top News Gainers
3/13 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 11.2%
6/16 UniQure NV weighs options including sale -Bloomberg [Reuters] 11.2%
10/25 Form 4 uniQure N.V. For: Oct 23 Filed by: Kapusta Matthew C 7.0%
5/10 uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B 7.0%
6/11 Uniqure NV (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at Janney Montgomery Scott. 5.9%
3/24 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.2%
1/31 Form 4 uniQure N.V. For: Jan 31 Filed by: van Deventer Sander 5.1%
5/16 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 4.3%
5/21 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 3.9%
4/24 Form 4 uniQure N.V. For: Apr 22 Filed by: Kapusta Matthew C 3.8%
Top News Decliners
9/4 uniQure Announces Proposed Public Offering -14.9%
5/12 Uniqure NV (NASDAQ: QURE) was given a new $81.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock. -7.0%
2/25 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.6%
7/29 Q2/2019 6/30/2019 EPS -0.830 ZacksConsensus N/A ActVsEst N/A - N/A -6.2%
9/5 uniQure Announces Pricing of its Public Offering -6.1%
3/6 Form 3/A uniQure N.V. For: Aug 07 Filed by: KLEMT CHRISTIAN -5.8%
1/29 Form 4 uniQure N.V. For: Jan 27 Filed by: Gut Robert -5.8%
3/2 Form 424B5 uniQure N.V. -5.6%
8/23 Form 4 uniQure N.V. For: Aug 21 Filed by: Kapusta Matthew C -5.0%
5/1 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $71.00 price target on the stock. -4.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3